Table 1 Sensitivity for the detection of intraperitoneal lesions with PET and BLI depending on the site of the tumour
n | Site or region | Volume range | Sensitivity PET | Sensitivity BLI |
|---|---|---|---|---|
[mm3] | [%] | [%] | ||
8 | Injection site | 0.3–9.0 | 63 (5/8) | 100 (8/8) |
2 | Peritoneum | 1.0–1.8 | 50 (1/2) | 100 (2/2) |
7 | Diaphragm | 0.1–1.8 | 14 (1/7) | 0 (0/7) |
13 | Liver surface | 0.5–3.0 | 85 (11/13) | 8 (1/13) |
1 | Stomach | 0.5 | 100 (1/1) | 0 (0/1) |
1 | Duodenum | 3.0 | 100 (1/1) | 0 (0/1) |
21 | Jejunum | 0.5–10.0 | 84 (16/21) | 48 (10/21) |
6 | Colon | 0.5–6.0 | 80 (4/6) | 33 (2/6) |
19 | Pancreas | 1.0–18 | 83 (15/19) | 79 (15/19) |
2 | Uterus | 1.8–3.0 | 100 (2/2) | 100 (2/2) |
2 | Bladder | 1.8–4.0 | 50 (1/2) | 0 (0/2) |
82 | Total | 0.1–18.0 | 74 (58/82)* | 49 (40/82)* |